Kevin Cannon

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

Brandon Essink, Charu Sabharwal, Kevin Cannon et al. · Clinical Infectious Diseases · 2021 · 172 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination

Kevin Cannon, Charles Elder, Mariano Young et al. · Vaccine · 2021 · 83 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

Stephan Bart, Kevin Cannon, Darrell T. Herrington et al. · Human Vaccines & Immunotherapeutics · 2016 · 57 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · medRxiv · 2021 · 40 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15